Cisplatin and doxorubicin repress Vascular Endothelial Growth Factor expression and differentially down-regulate Hypoxia-inducible Factor I activity in human ovarian cancer cells
Monique C A Duyndam
, Maria P A van Berkel
, Josephine C. Dorsman
, Davy A P Rockx
, Herbert M. Pinedo
, Epie Boven
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Cisplatin and doxorubicin repress Vascular Endothelial Growth Factor expression and differentially down-regulate Hypoxia-inducible Factor I activity in human ovarian cancer cells'. Together they form a unique fingerprint.